Total Cost of Revenue
Incyte Total Cost of Revenue decreased by 13.7% to $104.52M in Q1 2026 compared to the prior quarter. Year-over-year, this metric grew by 42.8%, from $73.19M to $104.52M. Over 4 years (FY 2021 to FY 2025), Total Cost of Revenue shows an upward trend with a 25.3% CAGR. This increase may warrant attention — for this metric, lower values are generally preferred.
Analysis
How to read this metric
An increase relative to revenue suggests margin compression, while a decrease indicates improved manufacturing efficiency or favorable product mix.
Detailed definition
Total cost of revenue includes the direct costs associated with manufacturing, packaging, and distributing pharmaceutica...
Peer comparison
Highly comparable across pharmaceutical firms, though variations exist based on whether drugs are manufactured in-house or outsourced.
total_cost_of_revenueHistorical Data
| Q2 '21 | Q3 '21 | Q4 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $38.03M | $39.87M | $43.87M | $42.61M | $50.64M | $54.58M | $59.16M | $56.82M | $68.33M | $60.09M | $69.75M | $60.96M | $76.63M | $85.99M | $88.49M | $73.19M | $78.77M | $99M | $121.18M | $104.52M |
| QoQ Change | — | +4.8% | +10.0% | -2.9% | +18.8% | +7.8% | +8.4% | -4.0% | +20.2% | -12.1% | +16.1% | -12.6% | +25.7% | +12.2% | +2.9% | -17.3% | +7.6% | +25.7% | +22.4% | -13.7% |
| YoY Change | — | — | — | — | +33.2% | +36.9% | +34.8% | +33.3% | +34.9% | +10.1% | +17.9% | +7.3% | +12.2% | +43.1% | +26.9% | +20.1% | +2.8% | +15.1% | +36.9% | +42.8% |
Business Segments
| Segment | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 |
|---|---|---|---|---|---|
| Reportable Segment | $73.19M | $78.77M | $99M | $121.18M | $104.52M |
| Total | $73.19M | $78.77M | $99M | $121.18M | $104.52M |
Total Cost of Revenue at Other Companies
Frequently Asked Questions
- What is Incyte's total cost of revenue?
- Incyte (INCY) reported total cost of revenue of $104.52M in Q1 2026.
- How has Incyte's total cost of revenue changed year-over-year?
- Incyte's total cost of revenue increased by 42.8% year-over-year, from $73.19M to $104.52M.
- What is the long-term trend for Incyte's total cost of revenue?
- Over 4 years (2021 to 2025), Incyte's total cost of revenue has grown at a 25.3% compound annual growth rate (CAGR), from $150.99M to $372.13M.
- What does total cost of revenue mean?
- The direct costs incurred to produce and deliver the goods or services sold by the company.